FDA Approved: PIRFENIDONE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for pirfenidone submitted by ScieGen Pharmaceuticals, Inc., authorizing an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

SUPPL AP for PIRFENIDONE (PIRFENIDONE)